29 Recruiting Solid Tumor Phase 2 Clinical Trials
Active phase 2 studies for solid tumor enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumor studiesPhase 2 Studies for Solid Tumor
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites) — Basking Ridge, New Jersey
View Study & Checklist ➔Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
📍 Stanford Cancer Institute — Palo Alto, California
View Study & Checklist ➔Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
📍 Phoenix Children'S Hospital — Phoenix, Arizona
View Study & Checklist ➔Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
📍 HonorHealth Research — Scottsdale, Arizona
View Study & Checklist ➔A Study of NDI 1150-101 in Patients With Solid Tumors
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
📍 Community Clinical Research Center — Anderson, Indiana
View Study & Checklist ➔Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
📍 Banner University Medical Center Tucson Campus — Tucson, Arizona
View Study & Checklist ➔Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
📍 Hackensack University Medical Center PARTNER — Hackensack, New Jersey
View Study & Checklist ➔Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
📍 Aflac Cancer & Blood Disorders Centers — Atlanta, Georgia
View Study & Checklist ➔FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
📍 Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
📍 NEXT Oncology — San Antonio, Texas
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
📍 ACRC/Arizona Clinical Research Center, Inc — Tucson, Arizona
View Study & Checklist ➔A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
📍 I-Mab Site 1016 — Goodyear, Arizona
View Study & Checklist ➔A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
📍 Site-113 — Duarte, California
View Study & Checklist ➔Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
📍 Gabrail Cancer Center — Canton, Ohio
View Study & Checklist ➔Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
📍 CBCC Global Research Site 001 — Scottsdale, Arizona
View Study & Checklist ➔A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
📍 Christiana Care Health System - Newark- Site Number : 8400011 — Newark, Delaware
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
📍 Adventist Health Glendale — Glendale, California
View Study & Checklist ➔First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔SMP-3124LP in Adults With Advanced Solid Tumors
📍 Cedars Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
📍 City of Hope — Duarte, California
View Study & Checklist ➔RAPA-201 Therapy of Solid Tumors
📍 Hackensack University Medical Center — Hackensack, New Jersey
View Study & Checklist ➔VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
📍 Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois
View Study & Checklist ➔